Scientific Issues Committee

Lorraine Kalia
Chair

Per Svenningsson
Vice-Chair

MDS Staff Liaison: Sarah Wahlstrom Helgren

Committee Purpose
To prepare statements on scientific and ethical issues related to Movement Disorders, as well as review those prepared by others on behalf of the Society, and analyze new and existing treatments and make recommendations regarding their role in the treatment of patients with Movement Disorders.

Read Society's statement cautioning against unproven stem cell therapies for Parkinson's disease.

Committee Members
Jane Alty
Alexander Balck
Daniela Berg
Per Borghammer
Inas Elsayed
Yue Huang
Walaa Kamel Elsayed
Jeffrey Kordower
Alexander Lehn
Michele Matarazzo
Tiago Mestre
Tiago Outeiro
Gian Pal
Santiago Perez Lloret
Roopa Rajan
Sephira Ryman
Giorgia Sciacca

Resource Type

Published paper

Please wait while we gather your results.

Published Papers

Published paper

The Management of Parkinson's Disease Before, During and After Pregnancy — an MDS Scientific Issues Committee Review

Read the paper

Resource Type

Published paper

Published paper

Movement Disorders Society Viewpoint on Biological Frameworks of Parkinson's Disease: Current Status and Future Directions

Read the paper

Resource Type

Published paper

Published paper

Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis

Read the paper

Resource Type

Published paper

Published paper

A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson’s Disease

Read the paper

Resource Type

Published paper

Published paper

Addressing the challenges of clinical research for freezing of gait in Parkinson’s disease

Read the paper

Resource Type

Published paper

Published paper

Discussion of Research Priorities for Gait Disorders in Parkinson’s Disease

Read the paper

Resource Type

Published paper

Features

Articles and stories about the group.

Please wait while we gather your results.

Research priorities on the role of α-synuclein in Parkinson's disease pathogenesis

March 2022

The MDS Scientific Issues Committee identified major barriers and clinical priorities regarding the research on αSyn’s role in PD, and provided recommendations.